Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bone Mineral Density Most Important Determinant of Fracture Risk

Reuters Staff  |  September 7, 2018

NEW YORK (Reuters Health)—In what is believed to be the largest study investigating genetic and clinical determinants of osteoporotic fracture risk, only a genetic predisposition to low bone mineral density (BMD) had a potential causal role to play.

“Notably, genetic predisposition to lower levels of vitamin D and estimated calcium intake from dairy sources were not associated with fracture risk,” the researchers report in The BMJ, online August 29.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“These findings suggest that interventions aimed at increasing bone strength are more likely to prevent fractures than widespread supplementation with vitamin D,” Dr. Brent Richards, a senior author on the paper, from Jewish General Hospital and McGill University in Montreal, Canada, said in a news release.

The study team did a meta-analysis of data from genome-wide association studies (GWAS) and performed Mendelian randomization studies to assess the causal effect of a host of factors thought to be associated with osteoporotic fracture, including vitamin D levels, calcium intake, fasting glucose levels, age of puberty and menopause, diabetes and rheumatoid arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Using data from more than 37,800 fracture cases and more than 227,000 controls, they identified 15 genetic loci associated with fracture risk. They then replicated their findings in more than 147,000 fracture cases and 150,000 controls.

Of the 15 fracture-associated loci, all were also associated with BMD and mapped to genes clustering in pathways known to be critical to bone biology or novel pathways, the authors report.

Mendelian-randomization analyses showed a “clear effect” of BMD on fracture risk. One standard deviation decrease in genetically determined BMD of the femoral neck was associated with a 55% increase in fracture risk, they report.

Hand grip strength, a proxy for muscle mass, was inversely associated with fracture risk, but this result was not significant after multiple testing correction.

“Despite high statistical power, none of the other tested and well accepted risk factors (eg, rheumatoid arthritis and other causes of secondary osteoporosis) or any of the other clinically relevant risk factors (vitamin D levels, dairy food derived calcium intake, fasting glucose, type 2 diabetes, and coronary heart disease) had evidence of a major causal effect on fracture risk,” the authors write in their paper.

This study provides evidence against a causal effect of several proposed clinical risk factors for fractures and further shows that genetic predisposition to lower vitamin D levels and estimated calcium intake from dairy sources are not associated with fracture risk, the authors say.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:bone mineral density (BMD)fracture riskfracture risk determinantFracturesOsteoporosis

Related Articles

    Unexpected Benefits of Bisphosphonates after Hip Fracture

    February 3, 2012

    Recent trials show this bisphosphonates can reduce subsequent hip fractures and mortality, while remaining cost effective.

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    Improve RA Care with Vitamin D

    November 16, 2015

    Background Autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythema­tous, occur when the body attacks its own tissue because it cannot differentiate between self and non-self. This is mainly through deregulation of the immune system. Vitamin D has been known to play a critical role in bone mineralization and bone health. Activated vitamin…

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences